Skip to Content
Morningstar

Virtus LifeSci Biotech Products ETF BBP

Morningstar Medalist Rating
Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBP

Will BBP outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable BBP’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the BBP management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of BBP’s parent organization’s priorities and whether they’re in line with investors’ interests.

Virtus LifeSci Biotech Products ETF's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBP

More BBP Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 27.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Tarsus Pharmaceuticals Inc Ordinary Shares

3.79 685,922
Healthcare

ADMA Biologics Inc

3.15 569,644
Healthcare

SpringWorks Therapeutics Inc Ordinary Shares

2.68 484,637
Healthcare

Agios Pharmaceuticals Inc

2.63 475,947
Healthcare

Sarepta Therapeutics Inc

2.63 475,215
Healthcare

Lexicon Pharmaceuticals Inc

2.62 474,809
Healthcare

Moderna Inc

2.54 458,963
Healthcare

Ascendis Pharma A/S ADR

2.49 450,963
Healthcare

Intra-Cellular Therapies Inc

2.47 447,333
Healthcare

Ligand Pharmaceuticals Inc

2.45 443,880
Healthcare